The Clorox Company (NYSE:CLX) Shares Acquired by Southland Equity Partners LLC

Southland Equity Partners LLC increased its holdings in shares of The Clorox Company (NYSE:CLX) by 51.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,741 shares of the company’s stock after acquiring an additional 1,618 shares during the period. Southland Equity Partners LLC’s holdings in Clorox were worth $770,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CLX. Mizuho Securities USA LLC grew its stake in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP boosted its holdings in Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after buying an additional 453,624 shares in the last quarter. International Assets Investment Management LLC grew its position in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after buying an additional 435,971 shares during the period. Boston Trust Walden Corp increased its holdings in Clorox by 5,442.5% in the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after buying an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in Clorox by 302.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after buying an additional 265,455 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.3 %

CLX opened at $160.81 on Friday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The business has a 50-day moving average of $163.93 and a two-hundred day moving average of $157.11. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market capitalization of $19.90 billion, a price-to-earnings ratio of 56.03, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share. On average, research analysts expect that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.03%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.04%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CLX shares. DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI cut their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Barclays lowered their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday, January 16th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.